Elisabet Figuerola-Bou

5PUBLICATIONS
33CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 14, 2025
KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma.

Elisabet Figuerola-Bou, Carla Ríos-Astorch, Enrique Blanco

|Nov 11, 2022
Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies.

Sara Sánchez-Molina, Elisabet Figuerola-Bou, Víctor Sánchez-Margalet

|Mar 31, 2022
Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1.

Daniel J García-Domínguez, Nabil Hajji, Roser López-Alemany

|Aug 04, 2021
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma.

Daniel J García-Domínguez, Nabil Hajji, Sara Sánchez-Molina

|Oct 24, 2020
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis.

Sara Sánchez-Molina, Elisabet Figuerola-Bou, Enrique Blanco

Pageof 1

Frequent Collaborators

4 joint publications

Sara Sánchez-Molina

4 joint publications

Daniel José García-Domínguez

4 joint publications

Enrique de Álava Casado

3 joint publications

Jaume Mora